Page last updated: 2024-12-05

propadiene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Propadiene, also known as allene, is a hydrocarbon with the formula H2C=C=CH2. It is the simplest allene, a type of compound with three consecutive carbon atoms, where the central carbon atom is sp hybridized and forms two double bonds. Propadiene is a colorless, flammable gas with a pungent odor. It is a highly reactive molecule, readily undergoing polymerization and addition reactions. Propadiene is not found naturally but is synthesized from various organic reactions. It is an important intermediate in organic synthesis, being used in the production of polymers, pharmaceuticals, and other fine chemicals. Research on propadiene focuses on its reactivity, its role in organic reactions, and its potential applications in various fields.'

Cross-References

ID SourceID
PubMed CID10037
CHEMBL ID116960
CHEBI ID37601
MeSH IDM0085739

Synonyms (39)

Synonym
12075-35-3
propadiene
inchi=1/c3h4/c1-3-2/h1-2h
allene
1,2-propadiene
ch2=c=ch2
dimethylenemethane
propa-1,2-diene
463-49-0
CHEBI:37601 ,
allene, >=95%
sym-allylene
un2200
einecs 207-335-3
hsdb 5135
CHEMBL116960
60731-10-4
propadiene, inhibited
4av0lz8qkb ,
unii-4av0lz8qkb
propadiene, inhibited [un2200] [flammable gas]
A827034
AKOS006221642
FT-0676084
propadiene-d4
propadiene [hsdb]
un 2200 (salt/mix)
DTXSID1029178
mfcd00008566
allene, purum, >=96.0%
Q422942
1,2-propadiene-1,3-diylidene
DTXSID801027035
P2848
allene (ca. 2% in tetrahydrofuran, ca. 0.4 mol/l)
P2847
P2846
allene (ca. 2% in n,n-dimethylformamide, ca. 0.4 mol/l)
allene (ca. 3.5% in toluene, ca. 0.7 mol/l)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
allenesAny olefinic compound having two double bonds from one carbon atom to two others.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (490)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (1.22)18.7374
1990's3 (0.61)18.2507
2000's204 (41.63)29.6817
2010's227 (46.33)24.3611
2020's50 (10.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.15 (24.57)
Research Supply Index6.21 (2.92)
Research Growth Index6.53 (4.65)
Search Engine Demand Index78.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.20%)5.53%
Reviews29 (5.87%)6.00%
Case Studies3 (0.61%)4.05%
Observational0 (0.00%)0.25%
Other461 (93.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]